Contribution of Estrone Sulfate to Cell Proliferation in Aromatase Inhibitor (AI) -Resistant, Hormone Receptor-Positive Breast Cancer

Aromatase inhibitors (AIs) effectively treat hormone receptor-positive postmenopausal breast cancer, but some patients do not respond to treatment or experience recurrence. Mechanisms of AI resistance include ligand-independent activation of the estrogen receptor (ER) and signaling via other growth...

Descripción completa

Detalles Bibliográficos
Autores principales: Higuchi, Toru, Endo, Megumi, Hanamura, Toru, Gohno, Tatsuyuki, Niwa, Toshifumi, Yamaguchi, Yuri, Horiguchi, Jun, Hayashi, Shin-ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882040/
https://www.ncbi.nlm.nih.gov/pubmed/27228187
http://dx.doi.org/10.1371/journal.pone.0155844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882040/
https://www.ncbi.nlm.nih.gov/pubmed/27228187
http://dx.doi.org/10.1371/journal.pone.0155844

Ejemplares similares